Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PRAD | rs146753238 | chr9:72858183 | C/T | 1.73E-5 | 493 | 30.8 | 31.35 | 22.45 | KM Plot |
PRAD | rs146851253 | chr15:83251513 | C/G | 3.09E-6 | 485 | 30.87 | 31.02 | 29.17 | KM Plot |
PRAD | rs146856055 | chr8:71541636 | C/T | 5.72E-7 | 492 | 31.25 | 29.97 | 24.27 | KM Plot |
PRAD | rs1468734 | chr16:5001304 | G/A | 5.2E-5 | 471 | 31.35 | 29.63 | 27.77 | KM Plot |
PRAD | rs146880902 | chr11:129974653 | GA/G | 2.0E-6 | 492 | 30.97 | 32.22 | 22.8 | KM Plot |
PRAD | rs146897955 | chr5:154158596 | C/CT | 0 | 489 | 30.27 | 33.47 | 4.87 | KM Plot |
PRAD | rs146951003 | chr1:93573825 | T/TTG | 2.23E-5 | 483 | 31.38 | 28.13 | 20.9 | KM Plot |
PRAD | rs146991082 | chr11:71558147 | G/A | 6.03E-5 | 491 | 31.27 | 26.8 | 20.93 | KM Plot |
PRAD | rs147055859 | chr2:204827209 | C/T | 3.27E-5 | 491 | 30.87 | 31.63 | 20.33 | KM Plot |
PRAD | rs147101217 | chr4:185166986 | G/A | 2.47E-11 | 491 | 31.65 | 28.1 | 20.93 | KM Plot |
PRAD | rs147234430 | chr5:154165782 | G/A | 0 | 491 | 30.2 | 33.47 | 4.87 | KM Plot |
PRAD | rs147248036 | chr15:83373033 | T/C | 4.15E-7 | 491 | 31.23 | 30.55 | 29.08 | KM Plot |
PRAD | rs147489102 | chr5:179022177 | TTACTAAAAA/T | 1.7E-12 | 485 | 30.73 | 35.8 | 18.88 | KM Plot |
PRAD | rs147557078 | chr2:242641864 | C/T | 0.000101 | 479 | 30.75 | 31.8 | 29.63 | KM Plot |
PRAD | rs147705898 | chr6:43304668 | GATATAT/G | 5.07E-10 | 485 | 31.27 | 28.57 | 44.3 | KM Plot |